Acute Kidney Injury in the Elderly

Clinics in Geriatric Medicine

Volumn 29, Issue 3, 2013, Pages 565-578

  Rosner, Mitchell H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Acute kidney injury; Dialysis; Elderly; Outcome

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINATED CONTRAST MEDIUM; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RASBURICASE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; AGE DISTRIBUTION; AGED; AGING; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ELDERLY CARE; FOLLOW UP; GERIATRIC PATIENT; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; MEDICAL CARE; MEDICAL HISTORY; MORBIDITY; MORTALITY; NEPHROLOGIST; OBSTRUCTIVE NEPHROPATHY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POLYPHARMACY; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; REVIEW; RISK REDUCTION; SHARED DECISION MAKING; TUMOR LYSIS SYNDROME;

ACUTE KIDNEY INJURY; DIALYSIS; ELDERLY; OUTCOME;

ACUTE KIDNEY INJURY; AGED; AGING; COMORBIDITY; HUMANS; INCIDENCE; KIDNEY; KIDNEY FUNCTION TESTS; ORGAN DYSFUNCTION SCORES; PATIENT OUTCOME ASSESSMENT; PATIENT SELECTION; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; RISK ADJUSTMENT; RISK FACTORS;

EID: 84880125185     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2013.05.001     Document Type: Review

References (75)

1. Lamiere N., Van Biesen W., Vanholder R. Acute kidney injury. Lancet 2008, 372:1863-1865.
2. Lo L.J., Go A.S., Chertow G.M., et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009, 76:893-899.
3. Hsu C.Y., Chertow G.M., McCulloch C.E., et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009, 4:891-898.
4. Liangos O., Wald R., O'Bell J.W., et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006, 1:43-51.
5. Hsu R.K., McCulloch C.E., Dudley R.A., et al. Temporal changes in incidence of dialysis-requiring AKI. JAm Soc Nephrol 2013, 24(1):37-42.
6. Feest T.J., Round A., Hamad S. Incidence of severe acute renal failure in adults: results of a community-based study. BMJ 1993, 306:481-489.
7. Turney J.H., Marshall D.H., Brownjohn A.M., et al. The evolution of acute renal failure. QJM 1990, 74:83-89.
8. Groeneveld A.B., Tran D.D., Van der Meulen J., et al. Acute renal failure in the intensive care unit: predisposing, complicating factors affecting outcome. Nephron 1991, 59:602-607.
9. Pascual J., Orofino L., Liano F., et al. Incidence and prognosis of acute renal failure in older patients. JAm Geriatr Soc 1990, 38:25-32.
10. Ali T., Khan I., Simpson W., et al. Incidence and outcome in acute kidney injury: a comprehensive population-based study. JAm Soc Nephrol 2007, 18:1292-1298.
11. Chronopoulos A., Rosner M.H., Cruz D.N., et al. Acute kidney injury in elderly intensive care patients: a review. Intensive Care Med 2010, 36:1454-1464.
12. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
13. Bagshaw S.M., Laupland K.B., Doig C.J., et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005, 9:R700-R709.
14. Schmitt R., Coca S., Kanbay M., et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008, 52:262-271.
15. Wald R., Quinn R.R., Luo J., et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009, 302:1179-1185.
16. Macedo E., Bouchard J., Mehta R.L. Renal recovery following acute kidney injury. Curr Opin Crit Care 2008, 14:660-665.
17. Rosner M. Acute kidney injury in the elderly: pathogenesis, diagnosis and therapy. Aging Health 2009, 5:1-10.
18. Turgut F., Balogun R.A., Abdel-Rahman E.M. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations. Clin J Am Soc Nephrol 2010, 5:1330-1339.
19. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
20. Stevens L.A., Li S., Wang C., et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010, 55:S23-S33.
21. Reis A.M., Cassiani S.H. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol 2011, 67:625-632.
22. Goyal V.K. Changes with age in the human kidney. Exp Gerontol 1982, 17:321-331.
23. Kaplan C., Pasternack B., Shah H., et al. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975, 80:227-234.
24. Lindeman R.D., Tobin J., Shock N.W. Longitudinal studies on the rate of decline in renal function with age. JAm Geriatr Soc 1985, 33:278-285.
25. Epstein M., Hollenberg N.K. Age as a determinant of renal sodium conservation in normal man. JLab Clin Med 1976, 87:411-417.
26. Fliser D., Zeier M., Nowack R., et al. Renal functional reserve in healthy elderly subjects. JAm Soc Nephrol 1993, 3:1371-1377.
27. Baylis C., Fredericks M., Wilson C., et al. Renal vasodilatory response to intravenous glycine in the aging rat kidney. Am J Kidney Dis 1990, 15:244-251.
28. Zhang X.Z., Qiu C., Baylis C. Sensitivity of the segmental renal arterioles to angiotensin II in the aging rat. Mech Ageing Dev 1997, 97:183-192.
29. Reckelhoff J.F., Kellum J.A., Blanchard E.J., et al. Changes in nitric oxide precursor, l-arginine and metabolites, nitrate and nitrite with aging. Life Sci 1994, 55:1895-1901.
30. Miura K., Goldstein R.S., Morgan D.S., et al. Age-related differences in susceptibilities to renal ischemia in rats. Toxicol Appl Pharmacol 1987, 87:284-292.
31. Schmitt R., Marlier A., Cantley L.G. Zag expression during aging suppresses proliferation after kidney injury. JAm Soc Nephrol 2008, 19:2375-2383.
32. Chen G., Bridenbaugh E.A., Akintola A.D. Increased susceptibility to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction. Am J Physiol Renal Physiol 2007, 292:F1272-F1281.
33. Cheung C.M., Ponnusamy A., Anderton J.G. Management of acute renal failure in the elderly patient: a clinician's guide. Drugs Aging 2008, 25:455-462.
34. Lavizzo-Mourey R., Johnson J., Stolley P. Risk factors for dehydration among elderly nursing home patients. JAm Geriatr Soc 1998, 36:213-220.
35. Lamiere N., Verspeelt J., Vanholder R., et al. Areview of the pathophysiology, causes and prognosis of acute renal failure in the elderly. Geriatr Nephrol Urol 1991, 1:77-87.
36. Perazella M.A., Markowitz G.S. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010, 8:461-470.
37. Chang Y.S. Hypersensitivity reactions to proton pump inhibitors. Curr Opin Allergy Clin Immunol 2012, 4:348-353.
38. Preston R.A., Stemmer C.L., Materson B.J., et al. Renal biopsy in patients 65 years of age or older. Analysis of the results of 334 biopsies. JAm Geriatr Soc 1990, 38:669-678.
39. Rakowski T.A., Winchester J.F. Renal biopsy in the elderly patient. Geriatric nephrology 1986, 37-39. Field Rich, New York. M.F. Michelis, H.G. Preuss (Eds.).
40. Keller F., Michaelis C., Buttner P., et al. Risk factors for long-term survival and renal function in 64 patients with rapidly progressive glomerulonephritis (RPGN). Geriatr Nephrol Urol 1994, 4:5-12.
41. Macias-Nunez J.F., Lopez-Novoa J.M., Martinez-Maldonado M. Acute renal failure in the aged. Semin Nephrol 1996, 16:330-336.
42. Pascual J., Liano F. Causes and prognosis of acute renal failure in the very old. Madrid Acute Renal Failure Study Group. JAm Geriatr Soc 1998, 46:721-725.
43. Perazella M.A., Parikh C.R. How can urine microscopy influence the differential diagnosis of AKI?. Clin J Am Soc Nephrol 2009, 4:691-693.
44. Perazella M.A., Coca S.G. Traditional urinary biomarkers in the assessment of hospital-acquired AKI. Clin J Am Soc Nephrol 2012, 7:167-174.
45. Dewitte A., Biais M., Petit L., et al. Fractional excretion of urea as a diagnostic index in acute kidney injury in intensive care patients. JCrit Care 2012, 27:505-510.
46. Rosner M.H., Bolton W.K. Renal function testing. Am J Kidney Dis 2006, 47:174-183.
47. Gill J., Malyuk R., Djurdjev O., et al. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group-a cautionary tale. Nephrol Dial Transplant 2007, 22:2894-2899.
48. Singbartl K., Kellum J.A. AKI in the ICU: definition, epidemiology, risk stratification and outcomes. Kidney Int 2012, 81:819-825.
49. Goldstein S.L. Acute kidney injury biomarkers: renal angina and the need for a renal troponin I. BMC Med 2011, 9:135.
50. Akposso K., Hertig A., Couprie R., et al. Acute renal failure in patients over 80years old: 25-years' experience. Intensive Care Med 2000, 26:400-406.
51. Van Den Noortgate N., Mouton V., Lamont C., et al. Outcome in a post-cardiac surgery population with acute renal failure requiring dialysis: does age make a difference?. Nephrol Dial Transplant 2003, 18:732-736.
52. Waikar S., Curhan G.C., Wald R., et al. Declining mortality in patients with acute renal failure, 1988 to 2002. JAm Soc Nephrol 2006, 17:1143-1150.
53. Xue J.L., Daniels F., Star R.A., et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. JAm Soc Nephrol 2006, 17:1135-1142.
54. Bagshaw S.M., George C., Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007, 11:R68.
55. Renal Physician Association shared decision making in the appropriate initiation of and withdrawal from dialysis. 2nd edition. Available at: Accessed December 13, 2012. http://www.renalmd.org/catalogue-item.aspx%3fid%3d682.
56. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008, 73:538-546.
57. Mehta R.L., Pascual M.T., Gruta C.G., et al. Refining predictive models in critically ill patients with acute renal failure. JAm Soc Nephrol 2002, 13:1350-1357.
58. Lins R.L., Elseviers M.M., Daelemans R., et al. Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrol Dial Transplant 2004, 19:2282-2288.
59. Chertow G.M., Soroko S.H., Paganini E.P., et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int 2006, 70:1120-1126.
60. Ishani A., Xue J.L., Himmelfarb J., et al. Acute kidney injury increases risk of ESRD among elderly. JAm Soc Nephrol 2009, 20:223-228.
61. Newsome B.B., Warnock D.G., McClellan W.M., et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008, 168:609-616.
62. James M.T., Ghali W.A., Tonelli M., et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010, 78:803-809.
63. Wunsch H., Guerra C., Barnato A.E., et al. Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA 2010, 303:849-856.
64. Hsu C.Y. Where is the epidemic in kidney disease?. JAm Soc Nephrol 2010, 21:1607-1611.
65. Matsushita K., Mahmoodi B.K., Woodward M., et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012, 307:1941-1951.
66. Chang J., Ronco C., Rosner M.H. Computerized decision support systems: improving patient safety in nephrology. Nat Rev Nephrol 2011, 7:348-355.
67. Brown J.R., Thompson C.A. Contrast-induced acute kidney injury: the at-risk patient and protective measures. Curr Cardiol Rep 2010, 12:440-445.
68. Pagkalis S., Mantadakis E., Mavros M.N., et al. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011, 66:251-259.
69. Howard S.C., Jones D.P., Pui C.H. The tumor lysis syndrome. NEngl J Med 2011, 364:1844-1854.
70. Parekh R., Care D.A., Tainter C.R. Rhabdomyolysis: advances in diagnosis and treatment. Emerg Med Pract 2012, 14:1-15.
71. Izzedine H., Launay-Vacher V., Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005, 45:804-817.
72. Perazella M.A., Moeckel G.W. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology and prevention/therapy. Semin Nephrol 2010, 30:570-581.
73. Mistro S., Maciel Ide M., de Menezes R.G., et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systemic review and meta-analysis. Clin Infect Dis 2012, 54:1774-1777.
74. Rivers E., Nguyen B., Havstad S., et al. Early goal directed therapy in the treatment of sepsis and septic shock. NEngl J Med 2001, 345:1368-1377.
75. Clinical practice guidelines for acute kidney injury 2012. Available at: Accessed December 16, 2012. http://www.kdigo.org/clinical_practice_guidelines/AKI.php.